| Literature DB >> 33720036 |
Fatimah Najihah Baderol Allam1, Mohd Ramadan Ab Hamid1, Siti Sabariah Buhari1, Harrinni Md Noor2.
Abstract
BACKGROUND: Hypertension is the root cause of many chronic diseases. Lifestyle changes (ie, dietary alterations and physical activity) are seen to be an important step in the prevention and treatment of hypertension. Educating people through web-based interventional programs could offer an effective solution and help these patients with hypertension in the existing health care scenario.Entities:
Keywords: blood pressure; dietary intake; education; hypertension; physical activity; website-based
Year: 2021 PMID: 33720036 PMCID: PMC8074856 DOI: 10.2196/22465
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
The search terms that were used by the researchers.
| Keywords | Synonymous terms |
| Web-based | Mobile health OR internet OR mhealth OR digital OR eHealth OR web application OR internet-enabled interactive multimedia OR internet-supported online OR technology-assisted OR computer-assisted OR website-delivered OR computer-based OR computer-delivered OR internet-based OR interactive computer-based OR e-learning OR website OR digital medicines OR digital health technology |
| Nutrition intervention | Diet intervention |
| Physical activity | Exercises |
| Hypertension | Hypertensive OR high blood pressure |
Figure 1Flow diagram depicting the inclusion of studies that used web-based dietary and physical activity intervention programs for patients with hypertension.
Characteristics of the published articles (n=15).
| Characteristics | n (%) | |
|
| ||
| 2011 | 1 (7) | |
| 2012 | 2 (13) | |
| 2013 | 0 (0) | |
| 2014 | 1 (7) | |
| 2015 | 1 (7) | |
| 2016 | 2 (13) | |
| 2017 | 2 (13) | |
| 2018 | 3 (20) | |
| 2019 | 3 (20) | |
| 2020 | 0 (0) | |
|
| ||
| England | 1 (7) | |
| United States | 5 (33) | |
| Canada | 4 (27) | |
| Spain | 1 (7) | |
| Korea | 2 (13) | |
| Italy | 1 (7) | |
| Taiwan | 1 (7) | |
|
| ||
| Original study | 12 (80) | |
| Protocol | 1 (7) | |
| Other: pilot study | 2 (13) | |
|
| ||
| Primary care | 11 (73) | |
| Tertiary care outpatient clinics | 1 (7) | |
| Integrated health care organization | 1 (7) | |
| Workplace | 1 (7) | |
| Unknown | 1 (7) | |
|
| ||
| Adult | 15 (100) | |
|
| ||
| Cardiovascular disease | 2 (11) | |
| Hypertension | 12 (67) | |
| Metabolic syndrome | 1 (6) | |
| Diabetes | 1 (6) | |
| Hyperlipidemia | 1 (6) | |
| Obesity | 1 (6) | |
aA few of the above studies assessed the tools in several contexts, for instance, to assess both mental health and diabetes in the patients.
Tool characteristics, intended use, and users (n=15). The table classifies variables according to unique tools rather than individual studies as the unit of analysis.
| Characteristics | n (%) | ||
|
| |||
|
| |||
| Website-based | 15 (100) | ||
| Software-based connected by the internet | 1 (7) | ||
| Telephone calls | 1 (7) | ||
| Native application | 2 (13) | ||
|
| |||
| Patient portal | 1 (7) | ||
| Electronic health record | 2 (13) | ||
| Digital management program | 1 (7) | ||
| Standalone | 11 (73) | ||
|
| |||
|
| |||
| One-way communication | 5 (33) | ||
| Two-way communication | 10 (67) | ||
|
| |||
| Unstructured communication (patient-provider free-form dialogue) | 8 (53) | ||
| Structured communication (tailored feedback) | 7 (47) | ||
|
| |||
| With 3 or more additional functions | 4 (27) | ||
| Linked to a health record | 3 (20) | ||
| Linked to appointment or scheduling | 2 (13) | ||
| Linked to viewable care or treatment plan | 2 (13) | ||
| Linked to prescription renewal | 1 (7) | ||
| Linked to laboratory or test results | 1 (7) | ||
| Linked to symptom diary or tracker | 1 (7) | ||
| Linked to disease information or education | 13 (87) | ||
| Linked to consultations | 2 (13) | ||
|
| |||
| Asynchronous | 9 (60) | ||
| Of asynchronous tools, time-limited (response from a provider within a specified time window) | 1 (7) | ||
| Synchronous | 5 (33) | ||
| Both | 1 (7) | ||
|
| |||
|
| |||
| Lifestyle or behavior modification | 13 (87) | ||
| Symptom reporting | 1 (7) | ||
| Care planning | 3 (20) | ||
| Medication adherence | 6 (40) | ||
| Not specified | 1 (7) | ||
|
| |||
| Nurse | 5 (33) | ||
| Physician | 9 (60) | ||
| Pharmacist | 2 (13) | ||
| Allied health professional | 5 (33) | ||
| Health advisor | 1 (7) | ||
| Not specified | 1 (7) | ||
|
| |||
|
| |||
| Did not provide compensation | 14 (93) | ||
| Did provide compensation | 1 (7) | ||
|
| |||
| Free through research participation | 13 (87) | ||
| Prior registration required via website or service | 2 (13) | ||
|
| |||
| Yes | 4 (27) | ||
| No | 11 (73) | ||
aA few of the studies used multiple variables. For instance, with regard to the communication medium, one study used web-based tools and telephone calls.
Assessment of the characteristics of unique studies (n=15). Unique studies were defined as the studies that led to several publications. These did not include editorials, protocols, or commentaries.
| Study design and evaluation characteristics | Value | |||
|
| ||||
|
| ||||
|
| Primary feature | 5 | ||
| Supplemental feature | 5 | |||
|
| Stage of studya | Evaluation | ||
|
| ||||
|
| Acceptability | 2 | ||
| Clinical | 8 | |||
| Psychological | 1 | |||
| Behavioral | 5 | |||
| Usage | 1 | |||
| Willingness | 1 | |||
| Cost-effectiveness | 1 | |||
|
| Sample size, median (IQR; range) | 264 (165.75-369.25; 106-9298) | ||
|
| Length of follow-up (months), median (IQR; range) | 12 (6.75-12; 4-12) | ||
| Nonrandomized studies (n=5) | N/Aa | |||
|
| ||||
|
| ||||
|
| Primary feature | 1 | ||
| Supplemental feature | 1 | |||
|
| Stage of studya | Evaluation | ||
|
| ||||
| Clinical | 2 | |||
| Sample size, median (IQR; range) | 429.5 (242.75-616.25; 56-803) | |||
| Length of follow-up (months), median (IQR; range) | 16 (12-20; 8-24) | |||
|
| ||||
|
| ||||
| Primary feature | 1 | |||
| Supplemental feature | 1 | |||
| Stage of studya | Feasibility and piloting | |||
|
| ||||
| Usage | 1 | |||
| Usability | 1 | |||
| Clinical | 1 | |||
| Sample size, median (IQR; range) | 370.5 (210.75-530.25; 51-690) | |||
| Length of follow-up (months), median (IQR; range) | 6.25 (4.875-7.625; 3.5-9) | |||
|
| ||||
|
| ||||
| Primary feature | 0 | |||
| Supplemental feature | 0 | |||
| Not specified | 1 | |||
| Stage of studya | Evaluation | |||
|
| ||||
| Usage | 1 | |||
| Sample size, n | 38 | |||
| Length of follow-up (months), n | 6 | |||
aThe definitions for the terms were derived from the 2008 Medical Research Council Framework for Evaluation of Complex Interventions.
bAll results in the study have been included. The multiple outcomes are counted from the individual studies.